(Q33630583)

28 July 2017

1 reference

title

Safety of treatment with oral anticoagulants in the elderly. A systematic review (English)

1 reference

28 July 2017

1 reference

1 reference

Hutten BA

1

1 reference

28 July 2017

Lensing AW

series ordinal

2

1 reference

28 July 2017

Kraaijenhagen RA

series ordinal

3

1 reference

28 July 2017

Prins MH

series ordinal

4

1 reference

28 July 2017

publication date

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

14

1 reference

28 July 2017

issue

4

1 reference

28 July 2017

page(s)

303-312

1 reference

Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.

28 July 2017

cites work

1 reference

12 December 2020

Trial of different intensities of anticoagulation in patients with prosthetic heart valves.

1 reference

12 December 2020

Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin

1 reference

12 December 2020

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

1 reference

12 December 2020

Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty

1 reference

12 December 2020

Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy

1 reference

12 December 2020

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

12 December 2020

Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole

1 reference

12 December 2020

Haemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis

1 reference

12 December 2020

Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort.

1 reference

12 December 2020

RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group

1 reference

12 December 2020

Anticoagulants in older patients. A safety perspective

1 reference

12 December 2020

A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation

1 reference

12 December 2020

Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Anticoagulants in the Secondary Prevention of Events in Coronary Thrombosis (ASPECT) Research Group

1 reference

12 December 2020

Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis

1 reference

12 December 2020

Evaluation of anticoagulants in patients with cerebral infarction with slight to moderate neurological deficit

1 reference

12 December 2020

Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients

1 reference

12 December 2020

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group

1 reference

12 December 2020

Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

1 reference

12 December 2020

Hemorrhagic complications of anticoagulant treatment

1 reference

12 December 2020

Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy

1 reference

12 December 2020

The international normalized ratio. A guide to understanding and correcting its problems

1 reference

12 December 2020

1 reference

12 December 2020

Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis

1 reference

12 December 2020

Anticoagulant therapy in recurrent cerebral embolism: a retrospective study in non-valvular atrial fibrillation

1 reference

12 December 2020

Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants.

1 reference

12 December 2020

The efficacy and safety of oral anticoagulation in patients with cancer

1 reference

12 December 2020

The effect of warfarin on mortality and reinfarction after myocardial infarction

1 reference

12 December 2020

Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis.

1 reference

12 December 2020

An audit of anticoagulation and endocarditis prophylaxis after heart valve surgery

1 reference

12 December 2020

Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding

1 reference

12 December 2020

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

12 December 2020

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

12 December 2020

Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks.

1 reference

12 December 2020

The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics

1 reference

12 December 2020

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

12 December 2020

Management of anticoagulation in outpatients: experience with an anticoagulation service in a municipal hospital setting

1 reference

12 December 2020

Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Second report of the Sixty Plus Reinfarction Study Research Group

1 reference

12 December 2020

The duration of oral anticoagulation after deep vein thrombosis. A randomized study

1 reference

12 December 2020

Bleeding classification in clinical trials: observer variability and clinical relevance.

1 reference

12 December 2020

Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group

1 reference

12 December 2020

Bleeding complications in oral anticoagulant therapy. An analysis of risk factors.

1 reference

12 December 2020

Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic

1 reference

12 December 2020

Warfarin sodium in prevention of deep venous thrombosis and pulmonary embolism in patients with fractured neck of femur

1 reference

12 December 2020

Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis

1 reference

12 December 2020

Anticoagulant prophylaxis, thromboembolism and mortality in elderly patients with hip fractures. A controlled clinical trial

1 reference

12 December 2020

Complications of long-term anticoagulation

1 reference

12 December 2020

Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis

1 reference

12 December 2020

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

12 December 2020

Randomised comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement.

1 reference

12 December 2020

Can old people on oral anticoagulants be safely managed as out-patients?

1 reference

12 December 2020

Anticoagulation for Prevention of Thromboembolism Following Fractures of the Hip

1 reference

12 December 2020

Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients

1 reference

12 December 2020

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

1 reference

12 December 2020

One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis.

1 reference

12 December 2020

Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis

1 reference

12 December 2020

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

1 reference

12 December 2020

Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis

1 reference

12 December 2020

Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group

1 reference

12 December 2020

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

1 reference

12 December 2020

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

12 December 2020

Treatment after transient ischemic attacks: a comparison between anticoagulant drug and inhibition of platelet aggregation

1 reference

12 December 2020

Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.

1 reference

12 December 2020

Safety of anticoagulation in the elderly: reasons for discontinuing therapy

1 reference

12 December 2020

Oral anticoagulant drugs

1 reference

12 December 2020

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

12 December 2020

"Therapeutic range" for oral anticoagulant therapy

1 reference

12 December 2020

A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip.

1 reference

12 December 2020

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

12 December 2020

Reliance on prothrombin time ratios causes significant errors in anticoagulation therapy

1 reference

12 December 2020

Hemorrhagic Complications of Anticoagulant Therapy

1 reference

12 December 2020

Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study

1 reference

12 December 2020

10.2165/00002512-199914040-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1011243162

0 references

Fatcat ID

release_7of5xspzyje5zhcml77taj6lsm

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7of5xspzyje5zhcml77taj6lsm

24 November 2022

mapped directly with Wikidata item

1 reference